In what is absolutely a sign that the new interest in psychedelic drugs has landed on the other side of The Pond, a new commercial facility has opened for trials in London.
Clerkenwell Health, a British start-up, will begin trials of psilocybin to help terminal patients manage the anxiety caused by this kind of diagnosis starting in August. The intent is to support trial participants through the end of palliative care. The facility will be located near Harley Street—a famed address globally for attracting doctors and firms offering state-of-the-art medical treatments and therapies. The firm will be working in cooperation
Read full article on High Times
